NOVOZYMES BIOINDUSTRIAL CHINA A/S: Financial statements 2021
CVR: 21599042
NOVOZYMES BIOINDUSTRIAL CHINA A/S (CVR 21599042) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -33,035 and a net result of DKK 56,066,583 compared with DKK 45,639,311 the year before. Equity amounted to DKK 828,817,662. The solvency ratio was 100%.
- Gross Profit
- -33,035 kr.
- Profit/Loss
- 56,066,583 kr.
- Equity
- 828,817,662 kr.
- Total Assets
- 828,848,912 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -33 t. | 56.1 mio. | 828.8 mio. | 0 |
| 2020 | - | -32 t. | 45.6 mio. | 817.8 mio. | 0 |
| 2019 | - | -38 t. | 283.5 mio. | 1.1 mia. | 0 |
| 2018 | - | -68 t. | -54 t. | 768.6 mio. | - |
| 2017 | - | -73 t. | -58 t. | 770.2 mio. | - |
Find more companies like NOVOZYMES BIOINDUSTRIAL CHINA A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
NOVOZYMES BIOINDUSTRIAL CHINA A/S has published its annual report for 2020. Gross profit came to DKK -31,924, and the net result was DKK 45,639,311.
As of January 18, 2021, Lars Green has joined the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of January 18, 2021, Randi Camilla Kinch Jensen has joined the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of January 18, 2021, Tina Sejersgård Fanø has left the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of January 18, 2021, Andrew Patrick Fordyce has left the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
About NOVOZYMES BIOINDUSTRIAL CHINA A/S
NOVOZYMES BIOINDUSTRIAL CHINA A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1999. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Lisbet Kragelund. The company is owned by NOVOZYMES A/S. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 119,380,365 compared with DKK 394,633,084 the year before. Equity amounted to DKK 1,018,536,331.
